Envoy Medical (COCHW) Stock Analysis & Winston Score
Envoy Medical is a medical device company that makes hearing implants for people with hearing loss. Its main product is the Acclaim, a fully implanted cochlear device — meaning the entire device goes inside the body with nothing visible on the outside. This makes it different from most hearing aids and cochlear implants, which have external parts that sit behind the ear or on the head. The company sells its devices to patients through hearing specialists and surgeons, primarily in the United States. Envoy Medical is very small, with a market cap near zero, and its financials show it is spending far more than it earns — a common situation for early-stage medical device companies still seeking broader regulatory clearance and commercial scale. The biggest risk is that the company must generate enough revenue to fund operations before running out of cash, as its deeply negative margins suggest it is not yet self-sustaining.
Winston Score: 16/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Weak (4/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.04
Market Cap: $1M
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ Capital Market
